Two months after Sputnik V, Russia approves second COVID-19 vaccine EpiVacCorona before advance testing
The vaccine has been approved ahead of a large scale advanced study that was scheduled to start in November or December. The results of the early-stage human trials of the vaccine have not yet been published
Russia 'Sputnik V' vaccine promises to help people develop immunity against COVID-19 for two years: Here's all you need to know
Sputnik V can only be used on people within the age groups of 18-60 as more studies need to ensure the vaccine is safe for older people.
Putin announces first 'registered' COVID-19 vaccine from Russia's Gamaleya Institute; his daughter among those inoculated
The Russian Health Minister has said that plans are in motion to start a mass vaccination campaign against the novel coronavirus in October.